Hercules, CA —— Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced financial results today for the first quarter ended March 31, 2013. First-quarter reported revenues were $499.7 million, up 2.8% compared to $486.3 million reported for the first quarter of 2012. These […]
CAMBRIDGE, Mass.–Firefly BioWorks announced today the awarding of three Firefly Frontiers Grants to leading researchers engaged in pushing the boundaries of microRNA research. The Frontiers Grant, a $10,000 award to be used on the company’s products, is designed to help scientists scale microRNA research from discovery to validation. Three of the Frontiers Grant winners are: […]
ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT: BTX) and subsidiary, LifeMap Sciences, today announced the release of the enhanced LifeMap BioReagents™ portal (https://bioreagents.lifemapsc.com/) featuring an improved user interface, product descriptions, and customer support options, as well as the addition of new PureStem™ progenitor cells to the site. These novel progenitors provide new and unique tools […]
Logos Biosystems, a provider of innovative life science research tools, today announced the introduction of a next generation automated cell counter, Luna-FL TM “Luna-FLTM fluorescence cell counter is a breakthrough for life science researchers”, said Neon Jung, CEO of Logos Biosystems. “We integrated dual fluorescence and bright field optics in one instrument to provide researchers […]
Albuquerque, New Mexico — IntelliCyt Corporation, a leading provider of assay screening solutions for phenotypic drug discovery, antibody discovery and in vitro toxicity testing, today announced it has completed an $8 million financing round. The financing was led by new investor Arboretum Ventures with participation from existing investors Prolog Ventures, Verge Fund, and New Mexico […]
Lucigen Corporation and Research Corporation Technologies (RCT) today announced a partnership to commercialize and distribute the CleanColi™ Expression System, the first Escherichia coli (E. coli)-based recombinant system that lacks unwanted endotoxin. Lucigen will produce and sell kits containing CleanColi™ competent cells and provide contract research services for the CleanColi™ Expression System. Lucigen simultaneously announces the […]
Sunnyvale, California, – Molecular Devices announced today the launch of FLIPR® Calcium 6 Assay Kits, the latest addition to their extensive range of calcium assay kits to address diversified GPCR and ion channel targets. Featuring a proprietary fluorophore, the dye offers the highest quantum yield of any calcium indicator on the market, delivering the greatest […]
SANTA BARBARA, CA and BERGISCH GLADBACH, GERMANY, —Miltenyi Biotec announced today that it has completed acquisition of Owl biomedical, Inc., an emerging company developing and commercializing microchip-based cell sorting systems using fully-closed disposable cartridges in an easy-to-use format. The acquisition underscores Miltenyi’s commitment to bringing comprehensive solutions to the research and clinical cell therapy markets. […]
Reorganisation of Roche Applied Science – part of Roche’s Diagnostics Division – designed to enhance responsiveness to scientific and market needs and technology flow from research use to the clinical setting. Changes expected to affect approximately 110 positions in Penzberg (Germany) and 60 positions in Branford (Connecticut, USA). Roche remains committed to life-science business. Roche […]
MaxCyte, Inc., the pioneer in scalable, high performance cell transfection systems, is hosting an educational webinar entitled “Streamlining HTS: Ion Channel, GPCR, and Transporter Assays in Biologically Relevant Cells using Large Scale Transfection” on Wednesday, April 24, 2013, from 11:00 AM — 12:00 PM EDT. Dr. Jinliang Sui, Senior Director of HTS & Bioinformatics at […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
